Get started
Wuxi Biologics (Cayman) IncWuxi Biologics (Cayman) IncWuxi Biologics (Cayman) Inc

Wuxi Biologics (Cayman) Inc

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

WXXWY chart

Key stats

Market capitalization
‪6.96 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
14.34
Basic EPS (TTM)
0.23USD
Net income
‪479.85 M‬USD
Revenue
‪2.40 B‬USD
Shares float
—
Beta (1Y)
0.75

About Wuxi Biologics (Cayman) Inc

Sector
Health Technology
Industry
Biotechnology
CEO
Zhi Sheng Chen
Website
wuxibiologics.com
Headquarters
Wuxi
Employees (FY)
‪12.74 K‬
Founded
2014
FIGI
BBG00HBQ0LQ7
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.